Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicVAX for Smoking Cessation
NCT00318383Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- May 2006
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NicVAX in nicotine dependence, sponsored by National Institute on Drug Abuse. Started May 2006; status: completed.
02
Drugs
NicVAX
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00318383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318383.